In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ChemDiv Inc.

http://www.chemdiv.com

Latest From ChemDiv Inc.

Deal Watch: Seattle Genetics Adds To Antibody-Drug Conjugate Portfolio

Looking to expand beyond Adcetris, Seattle Genetics pays $250m up front for Immunomedics' Phase I/II ADC for triple-negative breast cancer. Elsewhere in the ADC space, Swiss biotech Novimmune and South Korea's LegoChem are teaming up on a research collaboration.

Deals M & A

Deals Shaping The Medical Industry, February 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in January 2017

Deals BioPharmaceutical

Collaboration With Torrey Pines Adds To BioMotiv’s Early Momentum

The Cleveland-based biopharma accelerator company signs a $40 million agreement with Torrey Pines Investment to provide early-stage funding and development for innovations emerging from academic research. Previously, BioMotiv raised $46 million from investors to fund its model of accelerating breakthrough discoveries into mid-stage development.

BioPharmaceutical United States

Deals Shaping the Medical Industry (2/2012)

The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

Medical Device BioPharmaceutical
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • Other Names / Subsidiaries
    • ChemRar Ltd., Chemical Diversity Research Institute., ChemDiv Research Institute
UsernamePublicRestriction

Register